Dr. Sharma recognizes the potential of AI and ML in providing new approaches to depression treatments

Dr. Tonmoy Sharma, one of the leading experts in mental health and behavioral care, recognizes that Artificial Intelligence (AI) and Machine Learning (ML) provide huge possibilities in further improving treatments for depression. As depression is considered one of the most common mental health disorders in the world due to 300 million people suffering from it worldwide, it is important that health providers are continuously innovating their approaches to treatment because studies show that most patients with depression struggle with treatment.

 These available treatment options for depression do not produce similar results to patients because even if these patients deal with the same illness, the individual differences of the patients affect how the illness affects them and how they respond to treatment. These differences are the main consideration of Sovereign Health when providing care for their patients, as Dr. Sharma likes to emphasize.

Mental disorders like depression can be difficult to treat even if many treatment options are available now. According to Dr. Tonmoy Sharma, “…what happens when someone has a mental health disorder like depression or addiction is that they lose the ability to function properly; they lose the ability to plan things ahead, the ability to pay attention. ” The illness itself makes it difficult for the patient to live a normal life, but most of the time, the treatment poses another challenge for them. More often than not, patients experience a lot of trial and error in medication and treatments just so they could find the medication and treatment that works for them. This constant trial and error eventually takes a toll on patients, which leaves them either battling their depressive symptoms on their own or continuously subjecting themselves to further testing. Patients continue to suffer, and they carry this weight in their lives.

However, the good news is that science is persistent in addressing this concern about treating depression. Science, combined with new age technology like Artificial Intelligence (AI) and Machine Learning (ML), is persistent in finding new approaches that would help treat depression better. In a study published in the American Journal of Psychiatry and Nature Human Behavior, scientists are using AI and neuroimaging to innovate the ways of treating depression. In this study, electric activity is measured in the brain to determine a patient’s response to an antidepressant. Experts believe that these studies on AI and ML are beneficial in further improving depression treatments.

Sovereign Health, under the leadership of CEO Dr. Tonmoy Sharma, takes pride in providing evidence-based treatment to its patients. Aside from this evidence-based approach, Sovereign Health is also not hesitant to integrate the latest technology to further improve their services. As a matter of fact, a number of equipment used at Sovereign Health are based on AI and ML. This shows that Sovereign Health is committed to providing the best possible services for their patients.

Sovereign Health is successful in putting their patients’ needs into consideration when treating their conditions. This can be seen in their approaches such as pharmacogenetic testing, which identifies the most suitable drug depending on the DNA and metabolism of a patient, neurofeedback, which aims to condition the brain to have a different response to stimuli, and Transcranial Magnetic Simulation (TMS), which uses magnetic fields in stimulating and regenerating nerve cells.

Sovereign Health is a visionary in terms of providing mental health care for its patients. By always putting the patients’ needs first and keeping up with the latest technologies, it is not surprising that Sovereign Health is the leading treatment facility nationwide and will continue to be one.

This website uses cookies to ensure you get the best experience on our website. To find out more, read our updated privacy policy and cookie policy.